Pathophysiology of gadolinium-associated systemic fibrosis

Brent Wagner, Viktor Drel, Yves Gorin

Research output: Contribution to journalReview articlepeer-review

28 Scopus citations


Systemic fibrosis from gadolinium-based magnetic resonance imaging contrast is a scourge for the afflicted. Although gadolinium-associated systemic fibrosis is a rare condition, the threat of litigation has vastly altered clinical practice. Most theories concerning the etiology of the fibrosis are grounded in case reports rather than experiment. This has led to the widely accepted conjecture that the relative affinity of certain contrast agents for the gadolinium ion inversely correlates with the risk of succumbing to the disease. How gadolinium-containing contrast agents trigger widespread and site-specific systemic fibrosis and how chronicity is maintained are largely unknown. This review highlights experimentally-derived information from our laboratory and others that pertain to our understanding of the pathophysiology of gadolinium-associated systemic fibrosis.

Original languageEnglish (US)
Pages (from-to)F1-F11
JournalAmerican Journal of Physiology - Renal Physiology
Issue number1
StatePublished - Jul 1 2016


  • Fibrosis
  • Gadolinium
  • NADPH oxidase
  • Nephrogenic fibrosing dermopathy
  • Skin diseases

ASJC Scopus subject areas

  • Physiology
  • Urology


Dive into the research topics of 'Pathophysiology of gadolinium-associated systemic fibrosis'. Together they form a unique fingerprint.

Cite this